Variant report
Variant | esv3463779 |
---|---|
Chromosome Location | chr3:111243862-111250360 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113756996 | chr3:111243871-111243872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373004608 | chr3:111243873-111243874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs180759261 | chr3:111243888-111243889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554805748 | chr3:111243920-111243921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140665220 | chr3:111243922-111243923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375739852 | chr3:111243946-111243947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112834640 | chr3:111243947-111243948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557034568 | chr3:111243955-111243956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570808894 | chr3:111243973-111243974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148163899 | chr3:111243975-111243976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545910674 | chr3:111243976-111243977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185134871 | chr3:111244017-111244018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527852225 | chr3:111244020-111244021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs377096074 | chr3:111244060-111244061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142031764 | chr3:111244074-111244075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561200629 | chr3:111244096-111244097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189168478 | chr3:111244145-111244146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs373518201 | chr3:111244147-111244148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150608629 | chr3:111244188-111244189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112115040 | chr3:111244241-111244242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181887800 | chr3:111244245-111244246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143075788 | chr3:111244272-111244273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374975232 | chr3:111244273-111244274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73226209 | chr3:111244274-111244275 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185845437 | chr3:111244333-111244334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534766101 | chr3:111244339-111244340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554512571 | chr3:111244344-111244345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371405712 | chr3:111244405-111244406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115514029 | chr3:111244409-111244410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369135008 | chr3:111244422-111244423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537375420 | chr3:111244423-111244424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556973140 | chr3:111244470-111244471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs57998235 | chr3:111244475-111244476 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs376284905 | chr3:111244476-111244477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147489793 | chr3:111244494-111244495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112999228 | chr3:111244497-111244498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541611375 | chr3:111244534-111244535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113001553 | chr3:111244568-111244569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191738335 | chr3:111244569-111244570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4306850 | chr3:111244642-111244643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35553560 | chr3:111244643-111244644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563662776 | chr3:111244651-111244652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111256231 | chr3:111244653-111244654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112097812 | chr3:111244738-111244739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373542533 | chr3:111244739-111244740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528617541 | chr3:111244791-111244792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191492214 | chr3:111244810-111244811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182400199 | chr3:111244811-111244812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34780071 | chr3:111244814-111244815 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs57656690 | chr3:111244815-111244816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:111236400-111249600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr3:111243400-111244200 | Weak transcription | Placenta | Placenta |
3 | chr3:111243600-111249000 | Weak transcription | Primary B cells from peripheral blood | blood |
4 | chr3:111244200-111244400 | Enhancers | Placenta | Placenta |
5 | chr3:111245600-111246000 | Enhancers | Fetal Thymus | thymus |
6 | chr3:111249000-111250800 | Enhancers | Primary B cells from peripheral blood | blood |
7 | chr3:111249600-111249800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr3:111249800-111250200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr3:111250000-111250800 | Enhancers | Osteobl | bone |
10 | chr3:111250000-111251000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr3:111250200-111250400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr3:111250200-111250400 | Enhancers | HSMMtube | muscle |
13 | chr3:111250200-111250600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr3:111250200-111250800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |